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Abstract 
Purpose 
The purpose of this study is to 1) investigate the usefulness of five (5) objective early warning 
signs; 2) evaluate the relationships between objective signs with symptoms of COVID-19, and 3) 
assess the accuracy of ambient infrared forehead temperature with tympanic temperature. 
 
Methods 
Cross sectional data were collected at Wayne State University during the 2020-2021 semester. 
Blood oxygen levels and blood pressure were measured via automated pulse oximeters and blood 
pressure cuff, respectively. Body temperature was measured with an infrared thermometer via 
contact with the temple (temporal temp) and non-contact with the forehead (infrared temp). The 
smell test was conducted with two non-toxic scented markers. Participants were asked to identify 
each smell from a provided list. 
 
Results 
Twenty-nine participants (nineteen in the Fall 2020 semester and ten in the Winter 2021 
semester) consented to participate in vital sign testing. None of our participants confirmed a 
positive COVID-19 test. Therefore, only relationships between vital sign measurements were 
reported for these analyses (i.e. no COVID-19 positive versus COVID-19 negative analyses 
could be performed, as per the original study design).  No significant intra-variable correlations 
were revealed upon statistical analysis. Infrared and temporal temperatures were not correlated 
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with p=-0.252 and r=0.2196. A slight correlation between the fall and winter cohort was found 
for heart rate only with p=0.51. Three participants had an oxygen saturation (O2) reading ≤ 90%, 
without any associated symptoms. There were (non-significant) trends for those three 
participants with low O2 saturation levels to have higher heart rate (94±25bpm vs. 79±14bpm; 
p=0.11) and lower systolic blood pressure (111±21 vs. 120±12mmHg; p=0.27) compared with 
those participants with O2 readings >90% (low O2 vs. normal O2 saturations, respectively). 
 
Conclusion 
Non-contact infrared thermometers are inaccurate at or above 99.5ºF; thus, they are an 
ineffective way to screen for fever associated with COVID-19. Blood pressure is another 
ineffective method for screening due to the lack of research on how COVID-19 affects blood 
pressure without preexisting conditions. Heart rate could be another screening method; however, 
it is unknown how SARS-CoV-2 affects the heart due to lack of research. Participants with low 
oxygen saturation levels tended to have lower systolic blood pressures and higher heart rates, 
indicating physiological disruptions unrelated to a positive COVID-19 test and requires further 
investigation. Finally, smell may be a reliable method to screen for COVID-19 due to the high 
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Introduction 
The coronavirus disease 2019 pandemic has plagued the world and is characterized by mass 
shutdown, social isolation, conspiracy theories, and unprecedented vaccine development. First 
reported in Wuhan provenance in mainland China, SARS-CoV-2, the novel coronavirus, has 
been responsible for over 100 million positive cases and over 2.2 million deaths worldwide 
(WHO Coronavirus Disease dashboard, n.d). SARS-CoV-2 affects the respiratory system 
causing coronavirus disease 2019 (COVID-19), characterized by mild to severe symptoms (Hu et 
al., 2020). The easy transmissibility via expired respiratory droplets containing SARS-CoV-2 has 
led to a rapid global spread leading the World Health Organization to declare it a pandemic 
(Ghebreyesus Adhanom, 2020). Two distinct categories of infection have emerged, symptomatic 
cases and asymptomatic cases. Despite this, subtle physiological changes have suggested a 
spectrum of COVID-19 pathophysiology ranging from seemingly asymptomatic to severe. 
 
SARS-CoV-2 has four spike proteins on its outer envelope that allow it to bind to and infiltrate 
host cells (Indwiani Ysragil, 2020). Attracted to angiotensin-converting enzyme two receptor 
(ACE2), SARS-CoV-2 is prone to infect cells of the lower respiratory system (Rabi et al., 2020). 
A myriad of symptoms is caused by COVID-19 ranging from abnormal vital signs (Tobin et al., 
2020; Wang 2020) to a loss of olfaction (Whitcroft & Hummel, 2020) and gustation (Luers et al., 
2020). Due to the objective presentation of symptoms, screening patrons for entry to public 
spaces have become popular. Low blood oxygen saturation levels have been a commonly 
reported clinical sign leading to happy hypoxia without any dyspnea (Tobin et al., 2020). 
Further, SARS-CoV-2 can directly affect the heart by binding to the ACE2 receptors on the 
myocardium leading to myocarditis (Topol, 2020) and arrhythmias (Goha et al., 2020). The virus 
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also affects blood pressure by dysregulating the renin-angiotensin-aldosterone system (Topol, 
2020). Each of these signs has an easy, non-invasive way to measure and report.  
 
Screening via self-report of symptoms, travel disclosure, and non-contact forehead temperature 
checks has become widespread. However, self-report measures and ambient forehead 
thermometers have been shown to be inaccurate (Althubaiti, 2016; Niven, 2015). As such, the 
aims of this study are to 1) investigate the usefulness of five (5) objective early warning signs; 2) 
evaluate the relationships between objective signs with symptoms of COVID-19, and 3) assess 
the accuracy of ambient infrared forehead temperature with tympanic temperature.  
 
As the United States surpasses 571,000 deaths, the coronavirus pandemic remains an emergent 
health crisis. As such, we hypothesize that elevations in heart rate and blood pressure, with or 
without reductions in oxygen saturation and smell, may help identify “asymptomatic” SARS-
CoV-2 cases. Implementing simple, non-invasive screening methods can allow for the prediction 
and early detection of COVID-19.  
 
Increased screening methods are becoming more important as people who recover are left with 
severe, lasting symptoms. Persistent symptoms for three weeks after recovery is known as post-
acute COVID-19 (Greenhalgh et al., 2020), often referred to as “long-COVID.” Any symptoms 
present past that window are referred to as chronic-COVID (Chan et al., 2020). Long- and 
chronic-COVID affect those who had severe symptoms, as well as those with mild symptoms. A 
US study concluded that symptoms cease in a 14-to-21-day window for only 65% of people 
infected with COVID-19 (Tenforde et al., 2020). The most-reported post-acute symptoms are 
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cough, low-grade fever, and fatigue on the mild end of the spectrum (Nalbandian et al., 2021). 
Toward the more severe end, patients have presented with neurocognitive difficulties, 
gastrointestinal problems, and metabolic disruption (Dasgupta et al., 2020). 
 
Methods 
The present study is of cross-sectional design. Prospective data were to be collected once a week 
for in-person Life Fitness Activities (LFA) classes at Wayne State University in Detroit, MI, on a 
voluntary basis during the fall 2020 semester. However, due to the increasing status of the 
pandemic, data was only collected twice.  Cross-sectional data were collected at Wayne State 
University Campus Health Center COVID-19 testing sites on a voluntary basis during the winter 
2021 semester. All participants signed written informed consent before testing began for this IRB 
approved project (IRB-20-08-2665). 
 
Blood oxygen saturation (O2) levels and blood pressure were measured via automated pulse 
oximeters (Clinical Guard, Atlanta, GA, USA) and a blood pressure cuff (Omron, Model 
BP785N, Lake Forest, IL) respectively. Body temperature was measured using a dual infrared 
thermometer via contact with the temple (temporal temp) and non-contact with the forehead 
(infrared temp) (Mesanfit, Shenzhen, China). The smell test was conducted with two non-toxic 
scented markers Crayola Silly Scents Sweet and Smelly Markers, Easton, PA, USA). Participants 
were asked to identify each smell from a provided list. Participants were contacted via email 
after testing to follow up for positive test results.  
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 The blood pressure cuff was placed on the participant, and the pulse oximeter was placed on the 
index finger of the opposite hand. Temperature was taken first via non-contact with the forehead 
then with contact to the temple. After blood pressure and O2 saturation were recorded, 
participants were asked to pull their masks below their noses and identify the scent of two 
markers. Extra precautions were taken to prevent the stead of COVID-19. Researchers wore non-
latex disposable gloves and a mask. After data was collected, all equipment was disinfected 
using a chlorine-based surface disinfectant.  
 
Results 
Twenty-nine participants (nineteen in the Fall 2020 semester and ten in the Winter 2021 
semester) consented to participate in vital sign testing. None of our participants confirmed a 
positive COVID-19 test. Therefore, only relationships between vital sign measurements were 
reported for these analyses (i.e., no COVID-19 positive versus COVID-19 negative analyses 
could be performed, as per the original study design).   
 
The present study aimed to determine the usefulness of five non-invasive vital signs (blood 
pressure, oxygen saturation, pulse, heart rate, and smell), evaluate the relationship with 
subjective symptoms and objective signs and finally assess the accuracy of infrared temperature 
checks with temporal temperature checks. Statistical analysis was performed on all data. 
Descriptive statistics of the data set (n=29) are provided in table 1. An outlier in oxygen 
saturation (56%) was found to be more than three standard deviations from the mean and 
subsequently was removed from the results.  
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Infrared temp has a mean of 96.8±1.49º, n=29. Temporal temp averaged 98.47±1.57º, n=29. 
Systolic blood pressure and diastolic blood pressure averaged 119.17±13.26mmHg, n=29 and 
73.52±7.8mmHg, n=29, respectively. The heart rate mean is reported as 80.69±15.53bpm, n=29. 
O2 saturation with the outlier has a median of 95.17±8.13%. n=29. One outlier was identified 
(O2 of 56%) and when removed from the data set, the median became 96.57±3.11%. 
Relationships between each variable were run for correlations. No significant intra-variable 
relationships were found. 
 
 
Table 1. Descriptive statistics of data set. One O2 saturation outlier was removed due to being more than two 
standard deviations outside of the mean. 
Variable Valid N Mean Minimum Maximum Std.Dev. 
Infrared Temp. 29 96.8379 92.3 98.6 1.48647 
Temporal Temp. 29 98.4724 95.6 103.5 1.57001 
SBP 29 119.1724 88 157 13.26399 
DBP 29 73.5172 56 90 7.80394 
HR 29 80.6897 55 121 15.52901 
O2 Saturation 29 95.1724 56 99 8.12874 
O2 Saturation_NO OUTLIER 28 96.5714 84 99 3.10828 
 
 
Diastolic blood pressure (DPB) and systolic blood pressure (SBP) were not significantly related 
with a p=0.253, r=0.2192, n=29. Infrared temperature and temporal temperature are not 
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significantly correlated with p=0.252, r=0.2196, n=29. Heart rate (HR) and O2 saturation were 
not related with p=-0.543, r=-0.0119, n=28. HR and SBP are not related with p=0.956, r=-
0.0108, n=29. HR and DBP are not related with p=0.487, r=0.1343, n=29. This data is available 
in table 2. 
Table 2  Statistical analysis to show relationships. No relationships between variables were significant. Marked 
correlations are significant at p < 0.05000. 
Variable Infrared Temp. Temporal Temp. SBP DBP HR O2 Saturation_NO OUTLIER 
Infrared Temp. 1 0.2196 -0.1503 -0.1446 0.1918 0.103 
  N=29 N=29 N=29 N=29 N=29 N=28 
  p= --- p=.252 p=.436 p=.454 p=.319 p=.602 
Temporal Temp. 0.2196 1 -0.0775 -0.2337 0.2661 0.2667 
  N=29 N=29 N=29 N=29 N=29 N=28 
  p=.252 p= --- p=.690 p=.222 p=.163 p=.170 
SBP -0.1503 -0.0775 1 0.2192 -0.0108 -0.1845 
  N=29 N=29 N=29 N=29 N=29 N=28 
  p=.436 p=.690 p= --- p=.253 p=.956 p=.347 
DBP -0.1446 -0.2337 0.2192 1 0.1343 -0.3391 
  N=29 N=29 N=29 N=29 N=29 N=28 
  p=.454 p=.222 p=.253 p= --- p=.487 p=.078 
HR 0.1918 0.2661 -0.0108 0.1343 1 -0.1199 
  N=29 N=29 N=29 N=29 N=29 N=28 
  p=.319 p=.163 p=.956 p=.487 p= --- p=.543 
O2 Saturation_NO OUTLIER 0.103 0.2667 -0.1845 -0.3391 -0.1199 1 
  N=28 N=28 N=28 N=28 N=28 N=28 
  p=.602 p=.170 p=.347 p=.078 p=.543 p= --- 
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Table 3 shows statistics between Fall 2020 cohort and Winter 2021 cohort. Heart rate was the only factor that has a 
slight correlation. Group 1 is the Fall 2020 cohort. Group 2 is the winter 2021 cohort. 











Infrared Temp. 96.61 96.9579 -0.59207 27 0.558728 10 19 1.45255 1.52909 1.10818 0.913496 
Temporal 
Temp. 
98.01 98.7158 -1.15764 27 0.25715 10 19 1.3868 1.64055 1.39942 0.620907 
SBP 115 121.3684 -1.24073 27 0.225377 10 19 13.40812 13.0009 1.06363 0.865038 
DBP 71.4 74.6316 -1.06237 27 0.29748 10 19 7.21418 8.05682 1.24725 0.75988 
HR 73 84.7368 -2.04101 27 0.051136 10 19 10.42433 16.45142 2.49064 0.163766 




96.1111 96.7895 -0.53213 26 0.599154 9 19 4.67559 2.14939 4.73196 0.005933 
 
 
Data for the fall and winter semesters were compared to identify any relationships between 
cohorts. No significant relationships were observed, as seen in table 3. There was a small 
relationship between cohorts seen in heart rate with a p = 0.051. 
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Table 4 shows high O2 saturation versus low O2 saturation. Valid data was found with an O2 saturation above 
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Table 4 shows the difference between data sets when separated by high and low oxygen 
saturation. When separated, minor changes were seen between groups. The low O2 saturation 
group showed systolic blood pressure and higher diastolic blood pressure.  
 
Discussion 
Infrared thermometers are not an effective tool for pre-screening 
Infrared temperature measures of the forehead have become commonplace as a quick, non-
invasive way to screen for potential COVID-19 symptoms. The increased use of these tools has 
brought their inaccuracies to light. The “gold standard” of body temperature measurement is the 
pulmonary artery catheter (Bridges & Thomas, 2009). During this procedure, a catheter is 
inserted via a large vein, then it is directed into the pulmonary vein, where the temperature of the 
blood is recorded; this is considered a true “core body temperature” reading (Wright & 
Mackowiak, 2020). When measuring via pulmonary artery catheter, the “normal” value can be 
expected to be about 98.6ºF (37ºC) (Bridges & Thomas, 2009). Other common ways to take 
temperature include oral, tympanic, temporal, axilla, and rectal. Each method has its strengths 
and shortcomings. While no study to date has determined the correlation between these methods, 
the clinical review board of the non-profit organization, HealthWise, determined that rectal and 
tympanic temperatures are 0.5°F (0.3°C) to 1°F (0.6°C) higher than an oral temperature (Blahd 
et al., 2020). The review board also reports that axillary and temporal are 0.5°F (0.3°C) to 1°F 
(0.6°C) below oral readings (Blahd et al., 2020).  
 
A study in a neuroscience ICU concluded that measurements taken at the urinary bladder and 
temperatures taken via the pulmonary artery varied by 0.8ºC in 15% of patients. The study then 
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compared tympanic temperature measurements to bladder measures and found that 35% had a 
difference of 0.8ºC or higher, with 10% of those with a variance having a discrepancy of 1.5° C 
or greater (Dunleavy, 2010). These variances lead Wright and Mackowiak (2021) to argue that a 
proper encompassing body temperature does not exist; instead, there are only the temperatures of 
individual body parts. 
 
A more recent study published in the American Journal of Infection Control assessed the 
accuracy of non-contact infrared thermometers (NCIT) with temporal artery thermometers 
(TAT). Khan et al. (2020) found NCIT's to be related to TAT temperatures below 99.5ºF 
(37.5°C). When temperatures are at or above 99.5ºF (37.5°C), the mean differences widened 
considerably (Khan et al., 2020). In contrast with Khan et al., the current study found no 
correlation at any temperature, as seen in graph 1. The data collected during this study revealed 
no relationship between infrared temperature reading and temporal temperature reading. Also 
revealed upon statistical analysis is no correlation between fall and winter cohorts regarding 
temporal temperature (p=0.2572) and infrared temperature (p=0.5587), see figure 2. This 
concludes that both methods of temperature readings are not helpful for screening. Fall infrared 
temperature was expected to have been higher due to warmer weather and outside classes. This 
change was not observed. Increased inaccuracies due to ambient temperature (Shajkofci, 2021) 
further rendered infrared thermometers inadequate.  
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Figure 1 shows no relationship between temporal temperature and infrared temperature, p=0.252, n=29. Dashed 
lines represent upper and lower confidence intervals, while the solid line represents correlation. 
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Figure 2 shows differences between cohorts. X represents the mean of each group. Fall vs. winter infrared temp. has 
a p of 0.5587 and temporal temp. has a p of 0.2572. 
 
In the midst of a flu-like pandemic, accurate temperature checks have become a tool to protect 
and promote public health. The gold standard method to measure temperature remains an 
invasive procedure, not suitable for field testing. Another limiting factor affecting temperature 
checks is a lack of agreement surrounding an actual temperature (Chan, Kosik, & Wang, 2021). 
The US Center for Diseases Control and Prevention [CDC] (2017) lists the criterion of fever 
being a temperature reading of 100.4ºF or greater. As such, the errors in temperature readings 
above 99.5ºF render temperature measurements via non-contact infrared thermometers 
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impractical for COVID-19 screening. The inaccuracies at temperatures at or above 99.5ºF for 
NCIT's raise significant problems for the COVID-19 pandemic. 
 
Systolic blood pressure does not appear to be significantly linked to diastolic blood 
pressure 
Blood pressure is a large part of cardiovascular health, which is an essential indicator of overall 
health. As such, blood pressure is a common vital used to assess such health due to its ease of 
use and low cost. The virus that causes COVID-19 targets the cardiovascular system via the 
ACE2 receptor (Rabi et al., 2020). Individuals with previous high blood pressure are at an 
increased risk for a severe reaction to COVID-19 (Shah et al., 2021). The stress placed on the 
body by SARS-CoV-2 would be expected to increase blood pressure due to its effect on the 
renin-angiotensin-aldosterone system. To date, no study has assessed the effect of COVID-19 on 
blood pressure. The opposite has been studied in-depth, i.e., how hypertension affects COVID-
19 outcomes.  
 
The linear relationship between systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) is well studied and well understood (Pastor-Barriuso et al., 2003). SBP and DBP have 
been linked together in several studies, often demonstrating a systolic-versus-diastolic slope 
upon regression (Gavish, Ben-Dov, & Bursztyn, 2008). Both blood pressure readings coupled 
with pulse pressure have been shown to be highly related. These three factors are said to be so 
closely related that having two of the three provides enough data to determine the third. The 
present study found SBP and DBP are not significantly correlated with a p=0.253 and an 
r=0.2192, see figure 3. 
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Interestingly, the present article does not show a significant correlation; however, when SBP and 
DBP are plotted and tracked, the data shows SBP and DBP following each other in certain 
instances (see figure 4). Gavish, Ben-Dov, and Bursztyn (2008) explained this trend, citing that 
changes in DBP can be seen as more prominent changes in SBP. The present cohort did not show 
a high correlation; however, it did show similarities to previous studies in that regard.  
 
As previously mentioned, no study to date has examined if COVID-19 causes changes in blood 
pressure. As such, there is no significant research to determine if blood pressure monitoring 
would be a good method to screen for COVID-19. However, if blood pressure were commonly 
measured, individuals would be more in tune with their health. If a person trends with high blood 
pressure, they would be able to take more precautions to prevent COVID-19 infection and 
potential strong adverse reactions. 
 
Figure 3 Systolic blood pressure and diastolic blood pressure typically share a linear relationship. Seen in the 






























Figure 4 demonstrates some consistency of systolic blood pressure (SBP) to reflect changes in diastolic blood 
pressure (DBP).  
 
O2 Stats 
Oxygen (O2) saturation has been a perplexing piece of the SARS-CoV-2 puzzle. Hypoxia 
without any dyspnea has been seen in many patients and subsequently been given the term 
“happy hypoxia.” Patients have been reporting to hospitals with blood oxygen levels as low as 
50% (Tobin, Laghi, &amp; Jubran, 2020), which is contradictory to life and would potentially 
lead to brain damage or cell death. It is hypothesized that when SARS-CoV-2 s attaches to ACE2 
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Jubran, 2020). The human body is more sensitive to decreases in levels of blood carbon dioxide 
levels, which is not seen in COVID-19 infection. Based on this fact, we may be able to determine 
a better way to monitor COVID-19 patients. A study published in the Journal for Laboratory 
Medicine found that in a small population, COVID-19 patients show lower levels of oxygen and 
higher carbon dioxide levels in the blood (Elezagic et al., 2020). The Elezagic et al. study results 
open the door for a new way to screen for COVID-19. More studies are needed to validate CO2 
as an efficient screening method.  
 
The FDA reports that pulse oximeters have inaccuracies that are not clinically significant at 
normal O2 saturation levels (Center for Devices and Radiological Health, 2021). When O2 
saturation levels fall, the inaccuracies become more remarkable and more significant (Tobin, 
Laghi, & Jubran, 2020). Race has been revealed to play a factor in pulse oximetry inaccuracies 
as well. A 2020 study found that pulse oximeters over estimated O2 saturation in Black patients 
when arterial oxygen saturation was ≤88%, causing occult hypoxemia to be overlooked (Sjoding 
et al., 2020).  
 
The present study found no relationship between O2 saturation and other tested variables. 
However, the data did reveal differences in other variables when O2 saturation was low. In those 
tested, there was a tendency to show changes in heart rate and blood pressure. While we could 
not verify COVID-19 infection, there was something physiological occurring in the population. 
Larger sample size may further highlight these changes due to the potential inclusion of SARS-
CoV-2 positive individuals.  
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Other correlations expected to be present were between O2 saturation and blood pressure. 
Oxygen saturation has been shown to be correlated with systolic blood pressure above 80 mmHg 
(Hinkelbein, Genzwuerker, & Fiedler, 2005). However, the present study revealed a p = 0.347 
and r = -0.1845. The negative r value is particularly interesting due to the inverse relationship 
between these two variables.  
 
Using pulse oximetry for the screening of COVID-19 can be unreliable. Pulse oximeters show 
vast inaccuracies when O2 saturation is below 90%. COVID-19 patients can present with levels 
as low as 50%; thus, pulse oximeters are not helpful to detect new COVID-19 infections. Instead, 
using pulse oximeters for monitoring oxygen levels in those with a positive SARS-CoV-2 test 
could be a lifesaving tool. Home-bound COVID-19 patients can use a pulse oximeter to monitor 
their status and determine if they should seek medical attention or not. Further, many available 
pulse oximeters have not been approved by the FDA; thus, a more widely validated method for 
screening should be used. As previously mentioned, CO2 levels should be explored as a way to 
monitor infection.  
 
Other potentially useful screening methods 
The present study also attempted to validate smell as a potential screening method. All 
participants had the ability to determine a scent when asked; therefore, smell could not be 
validated. A smell test could be a quick and straightforward way to screen for COVID-19 due to 
nearly 60% of all COVID-19 patients presenting with hyposmia or anosmia (Whitcroft & 
Hummel, 2020). Loss of smell is more prevalent in COVID-19 patients than in other diseases 
(Printza & Constantinidis, 2020), and it is often one of the first symptoms to present, often 
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appearing three days after infection; as such, it could be a proper screening method in the face of 
the pandemic. A hypothetical danger to using a smell test could be the need to pull a mask down 
below the nose. This opens the participant up to potential infection, or the participant could 
release infectious particles into the air for others to become infected. 
 
Heart rate is another possible method for monitoring for COVID-19 infection. COVID-19 has 
demonstrated an ability to increase resting heart rate in a small perfect of COVID-19 patients 
(Quer et al., 2020). However, the study reported there was not a significant enough change to 
discern COVID-19 positive patients from negative patients. The effect COVID-19 has on heart 
rate needs to be further studied to gauge its usefulness in screening for SARS-CoV-2.  
  
Further benefits from the present study 
The COVID-19 pandemic has severely impacted general mental health. In the United States, 
40% of adults report worse mental health status in June 2020 than in June 2019 (Czeisler et al., 
2020). Implementing the extra safeguards tested in this study can lower these rates by allowing 
more people to interact. Thus, potential benefits from this study include an added level of 
protection during screening to allow for more in-person activities such as in-person classes.  
 
Limitations 
Potential limitations of the present study include small sample size, lack of follow-up, and lack 
of equilibration before taking blood pressure. Another significant limitation for the population is 
the requirement to be symptom-free. In order for students to be on campus, they must have been 
symptom-free for 48 hours and complete a questionnaire. Prospective investigations were 
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hampered by cancelled classes, quarantines, and positive tests which shut down remaining 
testing through much of Fall 2020.  
 
Conclusion 
The ongoing COVID-19 pandemic has brought to light flaws in well-established medical testing 
devices. The most prominent example of these is the inaccuracies of non-contact infrared 
thermometers. NCIT’s are inaccurate at temperatures at or above 99.5ºF; as such, they are an 
ineffective way to screen for fever associated with COVID-19. The present study revealed 
NCIT’s show no relationship between temporal temperatures and non-contact forehead 
measures, further reducing their accuracy for application. Blood pressure is another ineffective 
method for screening due to the lack of research on how COVID-19 affects blood pressure 
without preexisting conditions. Pulse oximeters show reduced accuracy when blood oxygen 
levels fall below 80%. Therefore, O2 saturation is not an effective way to screen for COVID-19 
infection due to the high prevalence of COVID-19 patients showing hypoxia as low as 50%. 
Heart rate could be another screening method; however, it is unknown how SARS-CoV-2 affects 
the heart due to lack of research. Finally, smell may be a reliable method to screen for COVID-
19 due to the high prevalence of anosmia and early presentation when infected.  
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